8 authorised products containing Everolimus, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Afinitor 10 mg Tablet EU/1/09/538/004 |
Everolimus | Novartis Europharm Limited | — |
| Afinitor 5 mg Tablet EU/1/09/538/001 |
Everolimus | Novartis Europharm Limited | — |
| Certican 0.25mg Tablets PA0896/005/001 |
Everolimus | Novartis Ireland Limited | Not marketed |
| Certican 0.75mg Tablets PA0896/005/003 |
Everolimus | Novartis Ireland Limited | Not marketed |
| Everolimus TAD 10 mg tablets PA0876/009/003 |
Everolimus | TAD Pharma GmbH | Not marketed |
| Everolimus TAD 2.5 mg tablets PA0876/009/001 |
Everolimus | TAD Pharma GmbH | Not marketed |
| Everolimus TAD 5 mg tablets PA0876/009/002 |
Everolimus | TAD Pharma GmbH | Not marketed |
| Votubia 1mg Dispersible tablet EU/1/11/710/016 |
Everolimus | Novartis Europharm Limited | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.